Synthesis of an Apionucleoside Family and Discovery of a Prodrug with Anti-HIV Activity

被引:25
|
作者
Toti, Kiran S. [1 ]
Derudas, Marco [2 ]
Pertusati, Fabrizio [2 ]
Sinnaeve, Davy [3 ]
Van den Broeck, Freya [3 ]
Margamuljana, Lia [4 ]
Martins, Jose C. [3 ]
Herdewijn, Piet [4 ]
Balzarini, Jan [4 ]
McGuigan, Christopher [2 ]
Van Calenbergh, Serge [1 ]
机构
[1] Univ Ghent, Fac Pharmaceut Sci, Lab Med Chem, B-9000 Ghent, Belgium
[2] Cardiff Univ, Cardiff Sch Pharm & Pharmaceut Sci, Cardiff CF10 3NB, S Glam, Wales
[3] Univ Ghent, Dept Organ Chem, NMR & Struct Anal Unit, B-9000 Ghent, Belgium
[4] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
NUCLEOSIDE PHOSPHONATES; ACTIVATION PATHWAY; APIOSE; ANALOGS; DIDEOXYNUCLEOSIDES; INHIBITOR; CHEMISTRY; MECHANISM; ADENINE; POTENT;
D O I
10.1021/jo500659e
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
We report the synthesis of a family of D- and L-furano-D-apionucleosides, their 3'-deoxy, as well as their 2',3'-dideoxy analogues with thymine and adenine nucleobases. Single carbon homologation of 1,2-O-isopropylidene-D-glycero-tetrafuranos-3-ulose (15) and optimized glycosylation conditions involving microwave irradiation were key to the successful synthesis of the target compounds. While all target nucleosides failed to show significant antiviral activity, we demonstrated that the triphosphate of 2',3'-deoxy-D-apio-D-furanoadenosine (1), in contrast to that of its D-apio-L-furanose epimer 2, was readily incorporated into a DNA template by HIV reverse transcriptase to act as a DNA chain terminator. This led us to convert adenine derivative 1 into two phosphoramidate prodrugs. ProTide 9b was found active against HIV-1 and HIV-2 (EC50 = 0.5-1.5 mu M), indicating that the lack of activity of the parent nucleoside, and possibly also other members of the D-apio-D-furanose nucleoside family must be sought in the inefficient cellular conversion to the monophosphate.
引用
收藏
页码:5097 / 5112
页数:16
相关论文
共 50 条
  • [31] Structural modifications of 5,6-dihydroxypyrimidines with anti-HIV activity
    Guo, Di-Liang
    Zhang, Xing-Jie
    Wang, Rui-Rui
    Zhou, Yu
    Li, Zeng
    Xu, Jin-Yi
    Chen, Kai-Xian
    Zheng, Yong-Tang
    Liu, Hong
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (23) : 7114 - 7118
  • [32] Cell Penetration and Secondary Structure of a Synthetic Peptide with Anti-HIV Activity
    Paneque, Taimi E.
    Ramirez-Suarez, Anna C.
    Casillas, Dionne
    Duarte, Carlos A.
    Chinea, Glay
    Espinosa-Vinals, Carlos
    Garay, Hilda
    Gomez-Perez, Llilian
    Fernandez-Ortega, Celia
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2017, 23 (04) : 531 - 539
  • [33] Development of Anti-HIV Agents Based on Chemical Biology
    Tamamura, Hirokazu
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2012, 132 (01): : 69 - 78
  • [34] Selectivity of kinases on the activation of tenofovir, an anti-HIV agent
    Varga, Andrea
    Graczer, Eva
    Chaloin, Laurent
    Liliom, Karoly
    Zavodszky, Peter
    Lionne, Corinne
    Vas, Maria
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 48 (1-2) : 307 - 315
  • [35] Review of Gabonese traditional plants that have reported anti-HIV activity
    Mounanga, Boukandou M. M.
    Traore, A. N.
    Van De Venter, M.
    Potgieter, N.
    INDIAN JOURNAL OF TRADITIONAL KNOWLEDGE, 2018, 17 (03): : 414 - 424
  • [36] Increased in vitro Anti-HIV Activity of Caffeinium-Functionalized Polyoxometalates
    Enderle, Ana G.
    Bosso, Matteo
    Gross, Rudiger
    Heiland, Magdalena
    Bollini, Mariela
    Culzoni, Maria J.
    Kirchhoff, Frank
    Muench, Jan
    Streb, Carsten
    CHEMMEDCHEM, 2021, 16 (17) : 2727 - 2730
  • [37] Synthesis of 9-substituted derivatives of berberine as anti-HIV agents
    Bodiwala, Hardik S.
    Sabde, Sudeep
    Mitra, Debashis
    Bhutani, Kamlesh Kumar
    Singh, Inder Pal
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (04) : 1045 - 1049
  • [38] Synthesis and Antimycobacterial Activity of Novel Amino Alcohols Containing Central Core of the Anti-HIV Drugs Lopinavir and Ritonavir
    Gomes, Claudia R. B.
    Moreth, Marcele
    Cardinot, Danielle
    Kopke, Valquiria
    Cunico, Wilson
    da Silva Lourenco, Maria Cristina
    de Souza, Marcus V. N.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 78 (06) : 1031 - 1034
  • [39] A Multi-targeted Drug Candidate with Dual Anti-HIV and Anti-HSV Activity
    Balzarini, Jan
    Andrei, Graciela
    Balestra, Emanuela
    Huskens, Dana
    Vanpouille, Christophe
    Introini, Andrea
    Zicari, Sonia
    Liekens, Sandra
    Snoeck, Robert
    Holy, Antonin
    Perno, Carlo-Federico
    Margolis, Leonid
    Schols, Dominique
    PLOS PATHOGENS, 2013, 9 (07)
  • [40] Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs
    Kushwaha, Prem Kumar
    Srivastava, Kumar Saurabh
    Kumari, Neha
    Kumar, Rajan
    Mitra, Debashis
    Sharon, Ashoke
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 56